CAPTRUST Financial Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$119K Buy
14,526
+1,884
+15% +$28.1K ﹤0.01% 3109
2026
Q2
$301K Buy
12,642
+1,648
+15% +$31.6K ﹤0.01% 2596
2026
Q1
$194K Buy
+10,994
New +$221K ﹤0.01% 2695
2022
Q3
– Sell
-227
Closed -$3K – 2125
2022
Q2
$3K Hold
227
– – ﹤0.01% 4275
2022
Q1
$3K Buy
+227
New +$2.04K ﹤0.01% 4332
2021
Q3
– Sell
-157
Closed -$4K – 4623
2021
Q2
$4K Buy
+157
New +$3.82K ﹤0.01% 3926

Other funds holding ALHC

CAPTRUST Financial Advisors's ALHC Position: Q3 2026 in Review

CAPTRUST Financial Advisors increased its Alignment Healthcare (ALHC) stake by 15% in Q3 2026, buying an estimated $28.1K and bringing the position to 14,526 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

CAPTRUST Financial Advisors first reported a position in ALHC in Q2 2021 and has held it in 6 quarters since. The position peaked at $301K in Q2 2026. 323 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • CAPTRUST Financial Advisors held 14,526 shares of Alignment Healthcare worth $119K as of Q3 2026.
  • CAPTRUST Financial Advisors bought 1,884 Alignment Healthcare shares in Q3 2026, an estimated $28.1K.
  • Alignment Healthcare made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3109 holding.
  • CAPTRUST Financial Advisors first reported a position in Alignment Healthcare in Q2 2021 and has held it in 6 quarters since.
  • CAPTRUST Financial Advisors's Alignment Healthcare position peaked at $301K in Q2 2026.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.